The firm is placing 7 million shares with a private investment partnership. It has not stated its intended use for the proceeds.
Cellular Dynamics International and Promega are embarking on a research collaboration to validate stem cell-based assays that can be used during drug development.
Researchers from the National Cancer Institute have developed an assay in mouse embryonic stem cells to distinguish between deleterious and neutral human BRCA1 mutations.
Researchers tie a variant in ADAMTS3 to breathing difficulties in dissimilar dog breeds, according to Discover's D-brief blog.
Parents of children with rare genetic disease have to contend with shifts in the interpretation of genetic variants, the Wall Street Journal reports.
The Japan Times reports that researchers sequenced the genome of a woman who lived during the Jomon period.
In Science this week: single-nucleus RNA sequencing of brain tissue from individuals with autism, and more.